Pinheiro Carina S, Martins Vicente P, Assis Natan R G, Figueiredo Bárbara C P, Morais Suellen B, Azevedo Vasco, Oliveira Sergio C
Departamento de Bioquímica, Imunologia do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil.
J Biomed Biotechnol. 2011;2011:503068. doi: 10.1155/2011/503068. Epub 2011 Oct 15.
The flatworm Schistosoma mansoni is a blood fluke parasite that causes schistosomiasis, a debilitating disease that occurs throughout the developing world. Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control schistosomiasis is through immunization with an antischistosomiasis vaccine combined with drug treatment. Several papers on Schistosoma mansoni vaccine and drug development have been published in the past few years, representing an important field of study. The advent of technologies that allow large-scale studies of genes and proteins had a remarkable impact on the screening of new and potential vaccine candidates in schistosomiasis. In this postgenomic scenario, bioinformatic technologies have emerged as important tools to mine transcriptomic, genomic, and proteomic databases. These new perspectives are leading to a new round of rational vaccine development. Herein, we discuss different strategies to identify potential S. mansoni vaccine candidates using computational vaccinology.
曼氏血吸虫这种扁形虫是一种血液吸虫寄生虫,可引发血吸虫病,这是一种在整个发展中世界都有发生的使人衰弱的疾病。当前的血吸虫病控制策略主要基于化疗,但许多研究人员认为,控制血吸虫病的最佳长期策略是通过接种抗血吸虫病疫苗并结合药物治疗。在过去几年里,已经发表了几篇关于曼氏血吸虫疫苗和药物研发的论文,这代表了一个重要的研究领域。能够对基因和蛋白质进行大规模研究的技术的出现,对血吸虫病新的潜在疫苗候选物的筛选产生了显著影响。在这种后基因组时代的背景下,生物信息学技术已成为挖掘转录组学、基因组学和蛋白质组学数据库的重要工具。这些新观点正引领着新一轮合理的疫苗研发。在此,我们讨论使用计算疫苗学来识别潜在曼氏血吸虫疫苗候选物的不同策略。